FDA Section 4 \u2022 who must NOT take this

Nizatidine - Contraindications

These conditions, allergies, and situations mean Nizatidine should NOT be used. From the US FDA-approved drug label Section 4.

Contraindication: Nizatidine oral solution is contraindicated in patients with known hypersensitivity to the drug.

Because cross-sensitivity in this class of compounds has been observed, H 2 -receptor antagonists, including nizatidine, should not be administered to patients with a history of hypersensitivity to other H 2 -receptor antagonists.

Does any of this apply to YOU?

Ask Health AI \u2192